The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Taylor Wessing LLP

24 HILLS ROAD, CAMBRIDGE, CB2 1JW, ENGLAND
Tel:
Work 01223 446400
Fax:
Fax 01223 446401
DX:
88010 CAMBRIDGE
Email:
Web:
www.taylorwessing.com
Amsterdam, Beijing, Berlin, Bratislava, Brno, Brussels and 18 more

East Anglia: Corporate and commercial

Corporate and commercial: Cambridge
Corporate and commercial: Cambridge - ranked: tier 1

Taylor Wessing LLP

Taylor Wessing LLP is 'very good, responsive to client needs and good value for money'. The firm 'beats local competitors for its commercial understanding and flexibility', says one client. Another remarks on the firm's 'fantastic service; it has a high level of knowledge of the growth equity market and is both responsive and reasonable value'. The UK corporate technology group, led from London by Adrian Rainey, includes founder member David Mardle, who is also co-head of the firm's international corporate practice and who is recommended for his 'depth of understanding'. Mardle advises on corporate transactions including trade sales and equity funding deals for both investors and companies seeking finance. He recently acted for Mina Holdings, which owns MiNA Therapeutics, on the £400m sale of shares to Sosei R&D Limited. Also recommended is associate Adam Thatcher in the firm's corporate technology group who advises investors and technology-focused companies, including start-ups, on venture capital investments, M&A transactions and general corporate matters. He worked with Rainey on £66.4m of investments by client Cambridge Innovation Capital. VC specialist Simon Walker left the firm to join investment bank Silverpeak.

Leading individuals

David Mardle - Taylor Wessing LLP

[back to top]

East Anglia: TMT (technology, media and telecoms)

Biotechnology
Biotechnology - ranked: tier 1

Taylor Wessing LLP

Taylor Wessing LLP's 'life science and drug discovery domain expertise is second-to-none in the UK; it has deep industry knowledge and response times are rapid'. The firm's domain expertise and focus on large venture capital transactions see it heavily involved in the biotechnology industry for clients based both in the innovation hub of Cambridge and overseas. Malcolm Bates and regulatory expert Tim Worden lead the transactional team and focus on complex global licensing, collaboration deals and contract disputes, as well as advising on IP and IT aspects of venture capital financings, joint ventures, M&A and IPOs. David Mardle, who is co-head of the firm's international corporate practice, also has extensive experience in equity funding transactions in the technology and life sciences sectors. The firm's client base includes leading names in the biotechnology sector such as French company TxCell and UK-based cell therapy company Oxford BioMedica. Bates recently advised pioneering RNA activation therapeutics company MiNA Therapeutics on a collaboration and licensing agreement with Boehringer Ingelheim for the development of new compounds to treat fibrotic liver diseases. He also handled commercial and IP agreements for Cambridge-based biotech Mission Therapeutics.

[back to top]

Intellectual property
Intellectual property - ranked: tier 1

Taylor Wessing LLP

At Taylor Wessing LLP 'domain expertise is second to none in the UK, response times are rapid and the breadth of knowledge is vital for clients'. The firm is known for its focus on the life sciences and technology sectors, and its transactional team in Cambridge specialises in complex global licensing, collaboration deals and contract disputes. Its client base comprises leading names in IP-rich industries such as telecoms, pharmaceuticals, biotechnology, chemicals, medical devices, electronics, software, automotive, cleantech and energy. Malcolm Bates, who is a partner in the IP and IT group and head of the life sciences practice, and specialist IP and regulatory partner Tim Worden are the key contacts. Their clients include Oxford BioMedica, Ceres Power, Teva and Cambridge Nanotherm. Recent highlights for Bates include advising French biotechnology company TxCell on a strategic manufacturing agreement with Lentigen Technology that could lead to first-in-man clinical studies targeting the prevention of chronic rejection after organ transplantation.

Leading individuals

Malcolm Bates - Taylor Wessing LLP

Tim Worden - Taylor Wessing LLP

[back to top]


Further information on Taylor Wessing LLP

Please choose from this list to view details of what we say about Taylor Wessing LLP in other jurisdictions.

United Arab Emirates

Offices in Dubai

Germany

Offices in Hamburg, Frankfurt, Berlin, Munich, and Dusseldorf

East Anglia

Offices in Cambridge

France

Offices in Paris

India

London

Offices in London

Netherlands

Offices in Amsterdam and Eindhoven

Poland

Offices in Warsaw

Ukraine

Offices in Kiev

Legal Developments in the UK

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to